Announcements Trials
Browse Landscape

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

CNS 9Breast 3Lymphoid 2Genitourinary 2Tumor-Agnostic 1Thoracic 1Head & Neck 1Gynecologic 1Gastrointestinal 1Endocrine 1

Conditions

Vision Disorders 1Pituitary Neoplasms 1

Interventions

lutetium Lu 177 dotatate 36Everolimus 32pembrolizumab 24Temozolomide 21Magnetic Resonance Spectroscopy 21Nivolumab 18lenvatinib 17gallium Ga 68 dotatate 16cabozantinib 15Cisplatin 15lanreotide 143-Iodobenzylguanidine 14Capecitabine 13trametinib 12dabrafenib 12Bevacizumab 12Octreotide 11Surveys and Questionnaires 10Surgical Procedures, Operative 10Sunitinib 10Radiosurgery 10Positron Emission Tomography Computed Tomography 10Blood Specimen Collection 10Sorafenib 9Paclitaxel 9Ipilimumab 9Carboplatin 9surufatinib 8Etoposide 8Doxorubicin 8

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Diffusion Tensor Imaging × Endocrine × Clear all
NCT03591315 2018-07-23

Clinical Study of Structural and Functional Evaluation of the Visual Pathway

Xiangya Hospital of Central South University

Unknown
60 enrolled
Endocrine

Pituitary Neoplasms, Vision Disorders

Data powered by HemOnc (CC BY 4.0) Colophon âš¡